Literature DB >> 2482774

Urodynamics in benign prostatic hyperplasia: a survey.

T Hald1.   

Abstract

Urodynamic investigations have been used in the diagnosis of prostatic obstruction for the last 30 years. The methods have changed, and the emphasis is now more on diagnosing borderline cases and ruling out obstruction than actually demonstrating the obstruction. The philosophy surrounding the clinical management of benign prostatic hyperplasia (BPH) is changing. Three concepts are useful in this context: the presence of actual prostatic enlargement, the symptomatology, and the presence of urodynamic obstruction. These items are not always present together. It is of extreme importance for our understanding of BPH to realize the way these concepts interrelate. The paper stresses the importance of detrusor-related phenomena in the symptomatology and urodynamics.

Entities:  

Mesh:

Year:  1989        PMID: 2482774     DOI: 10.1002/pros.2990150508

Source DB:  PubMed          Journal:  Prostate Suppl        ISSN: 1050-5881


  25 in total

Review 1.  Transurethral microwave thermotherapy in benign prostatic hyperplasia.

Authors:  P Minnee; F M Debruyne; J J de la Rosette
Journal:  Curr Urol Rep       Date:  2000-08       Impact factor: 3.092

2.  [Benign prostate hyperplasia].

Authors:  U Jonas; A I Gabouev; T R W Herrmann; K Höfner; M C Michel; M Alschibaja; R Hartung
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  The medical therapy of prostatic symptoms study: what will we learn?

Authors:  Kevin M Slawin
Journal:  Rev Urol       Date:  2003

4.  The medical therapy of prostatic symptoms study: what will we learn?

Authors:  Kevin M Slawin
Journal:  Rev Urol       Date:  2003

5.  [New developments for benign prostate syndrome].

Authors:  K Höfner
Journal:  Urologe A       Date:  2008-02       Impact factor: 0.639

6.  [Urology update seminar UroUpdate. Düsseldorf 27th-28th February 2009].

Authors:  U Ayazpoor
Journal:  Urologe A       Date:  2009-07       Impact factor: 0.639

7.  [Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

Review 8.  Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; E M Sorkin
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 9.  Alfuzosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in benign prostatic hyperplasia.

Authors:  M I Wilde; A Fitton; D McTavish
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

Review 10.  Early treatment of benign prostatic hyperplasia: implications for reducing the risk of permanent bladder damage.

Authors:  Andrea Tubaro; Simon Carter; Alberto Trucchi; Giorgio Punzo; Stefano Petta; Lucio Miano
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.